ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW
7,680.00
+80.00 (1.05%)
At close: Mar 6, 2026
ImmuneOncia Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.83 | -0.58 | -0.86 | 0.51 | 0.71 | 0.81 | |
| Net Debt / EBITDA Ratio | 1.56 | 0.97 | 2.40 | 1.90 | 3.86 | 1.77 | |
| Net Debt / FCF Ratio | 1.70 | 0.76 | 2.95 | 1.74 | 20.22 | 2.00 | |
| Asset Turnover | - | 0.02 | 0.00 | 0.18 | 0.00 | 0 | |
| Quick Ratio | 7.36 | 3.00 | 7.75 | 7.16 | 4.80 | 13.22 | |
| Current Ratio | 8.18 | 3.06 | 7.90 | 7.53 | 4.84 | 13.31 | |
| Return on Equity (ROE) | - | -22.97% | - | - | - | - | |
| Return on Assets (ROA) | - | -26.25% | -21.22% | -21.71% | -18.57% | -22.71% | |
| Return on Capital Employed (ROCE) | -55.30% | -63.90% | -38.80% | -47.30% | -28.10% | -46.10% | |
| Buyback Yield / Dilution | -27.73% | -7.35% | -0.64% | -12.17% | -904.47% | 0.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.